Mfn2 ablation causes an oxidative stress response and eventual neuronal death in the hippocampus and cortex
In subjects with T2DM, weekly administration of tirzepatide at doses of 5 mg, 10 mg, or 15 mg was associated with greater weight loss compared to placebo ( 6.3 kg, 8.4 kg, and 9.4 kg, respectively), and 1.7 kg, 4.8 kg, and 7.2 kg greater weight loss compared to selective GLP-1 receptor agonists, demonstrating a dose-dependent effect sustained for up to 2 years [48]
This means that under this classification these products have to be subjected to rigorous phase 1 and phase 2 clinical trials to first prove their safety and then their effectiveness
See more details: on.kff.org/ehbs2025 Meanwhile the grey market cost for a months supply of tirzepatide or semaglutide "research chemicals" is under $30.
The latest research and trials on the effect of GLP-1RAs in the eye were searched until April 2025, including thorough cellular studies, animal studies, and clinical observation surrounding glaucoma, diabetic retinopathy, and other ocular diseases
They secrete anti-inflammatory cytokines (e.g., IL-10, TGF-) and inhibit pro-inflammatory cell activation (118)
